SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report: ~~December~~March 511, ~~2012~~2014

JINZANGHUANG TIBET PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)


Delaware	0-53254	26-2443288
(State of other jurisdiction of	(Commission File No.)	(IRS Employer
incorporation or organization		Identification No.)

Leling Economic Development Zone, Kaiyuan East Blvd., Dezhou, Shandong Province, P.R. China 253600
(Address of principal executive offices) (Zip Code)


86-534-2111-962
(Registrant’s telephone number including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 45.~~01 Change~~02 Election inof ~~Registrant’s Certifying Accountant~~Directors

On ~~December~~March 511, ~~2012~~2014 the Registrant’s Board of Directors ofvoted ~~Jinzanghuang~~to ~~Tibet~~increase ~~Pharmaceuticals,~~the ~~Inc. approved~~number ~~the~~of ~~dismissal~~members of ~~Stan~~the ~~Jeong-Ha Lee~~Board to four, ~~CPA~~and ~~from~~elected ~~his~~Yahui ~~position~~Zhang to serve as a member of the ~~principal~~Board ~~independent~~of ~~accountant~~Directors. Information ~~for~~regarding ~~Jinzanghuang~~Mr. ~~Tibet~~Zhang ~~Pharmaceuticals~~follows.

Yahui Zhang. Yahui Zhang has been involved in the management of agricultural production since 1998. The Board ofhas ~~Directors~~elected ~~engaged~~Mr. ~~Stan~~Zhang ~~Jeong-Ha~~to ~~Lee,~~serve ~~CPA~~on asthe ~~principal~~Board ~~independent~~so ~~accountant~~that he can bring that experience to bear on ~~June~~the ~~21,~~Board’s ~~2012~~development of the Registrant’s business plan. ~~The~~Since ~~audit~~March ~~report~~8, 2013 Mr. Zhang has been employed as General Manager of ~~Stan~~the JInner Mongolia Branch of Leling Jinzanghuang Biotech Co.H., ~~Lee~~Ltd., ~~CPA~~an onentity ~~Jinzanghuang~~that ~~Tibet~~is ~~Pharmaceutical~~managed by a subsidiary of the Registrant and consolidated as a variable interest entity with the Registrant’s financial statements. From ~~for~~2009 to 2013 Mr. Zhang was employed as President of the ~~fiscal~~Inner ~~year~~Mongolia ~~ended~~Chifeng ~~June~~Xinganxian ~~30,~~Vegetable ~~2012~~Production ~~did~~and ~~not~~Marketing ~~contain~~Farmers anProfessional ~~adverse~~Cooperative. In ~~opinion~~that orposition ~~disclaimer~~he supervised the production and marketing of ~~opinion~~vegetables orby ~~qualification~~the orfarmers ~~modification~~in the cooperative. ~~Stan~~From ~~Jeong-Ha~~1998 ~~Lee~~to 2008, ~~CPA~~Mr. ~~did~~Zhang ~~not,~~was ~~during~~employed ~~the~~as ~~applicable~~General ~~periods~~Manager of Chifeng Lvhua Vegetable Plantation Co., ~~advise~~Ltd. In ~~Jinzanghuang~~1994 ~~Tibet~~Mr. ~~Pharmaceuticals~~Zhang ofwas ~~any~~awarded ofa ~~the~~Bachelor’s ~~enumerated~~Degree ~~items~~with ~~described~~a concentration in ~~Item~~Economics ~~304(a)(1)(iv)~~by ofthe ~~Regulation~~Inner ~~S-K~~Mongolia University. Yahui Zhang is 45 years old.

Jinzanghuang Tibet Pharmaceuticals and Stan Jeong-Ha Lee, CPA have not, during Jinzanghuang Tibet Pharmaceuticals’ most recent fiscal year or any subsequent period through the date of dismissal, had any disagreement on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to Stan Jeong-Ha Lee, CPA’s satisfaction, would have caused Stan Jeong-Ha Lee, CPA to make reference to the subject matter of the disagreement in connection with his reports.

Jinzanghuang Tibet Pharmaceuticals has requested Stan Jeong-Ha Lee, CPA to furnish a letter addressed to the Securities Exchange Commission stating whether or not Stan Jeong-Ha Lee, CPA agrees with the statements in this Form 8-K. A copy of the letter is filed as an exhibit to this 8-K.

On December 5, 2012 Jinzanghuang Tibet Pharmaceuticals retained KCCW Accountancy Corp. to audit Jinzanghuang Tibet Pharmaceuticals’ financial statements for the year ended June 30, 2013. At no time during the two most recent fiscal years and the subsequent interim period through December 5, 2012, the date of the engagement, did Jinzanghuang Tibet Pharmaceuticals consult with KCCW Accountancy Corp. regarding any matter of the sort described above with reference to Stan Jeong-Ha Lee, CPA, any issue relating to the financial statements of Jinzanghuang Tibet Pharmaceuticals, or the type of audit opinion that might be rendered for Jinzanghuang Tibet Pharmaceuticals.

Item 9.01 Financial Statements and Exhibits

Exhibits

16.1 Letter from Stan Jeong-Ha Lee, CPA

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	JINZANGHUANG TIBET PHARMACEUTICALS, INC.	~~JINZANGHUANG TIBET PHARMACEUTICALS, INC.~~
Dated: December 6, 2012		By:/s/ Xue Bangyi
Dated: March 12, 2014	By:/s/ Xue Bangyi
	Xue Bangyi	~~Xue Bangyi~~
	Chief Executive Officer	~~Chief Executive Officer~~

Filing Compare · JINZANGHUANG TIBET PHARMACEUTICALS, INC.